Coffee chat: Advanced proteomic analysis

ABSTRACT

Proteomics has often lagged behind genomics in the development of new technologies and approaches. However, in recent years the significant advancement of contemporary techniques for proteomic analysis, such as aptamer-based technologies, has opened the door to a new era of advanced proteomic analysis. In this Coffee Chat, our three experts explore the reasons for the delay in proteomic developments, review the current analytical technologies available for proteomics and reveal the recent advances in the field, before highlighting the pros and cons of specific techniques.

Speak with one of our experts

Contact us

Share with colleagues

More webinars

WebinarEvaluation of precision and correlation for the latest proteomic platforms

The field of proteomics is rapidly advancing, enabling precise measurement of thousands of proteins, particularly those in higher abundance. This webcast will explore significant differences in precision within and across the latest large-scale proteomic platforms and their intercorrelations, based on blind duplicate split assays of the leading modified aptamer-based 11K and antibody proximity ligation-based 5K platforms. Each platform exhibits distinct strengths and limitations, requiring careful consideration prior to implementation in individual studies.

Learn more

WebinarScaling Proteomics: Balancing Performance and Measuring Enough Proteins

As proteomics platforms have advanced, the number of proteins measured and sample throughput have dramatically increased. However, have sacrifices or trade-offs been necessary to make these gains? To find out, Stephen Williams will analyze how the performance of proteomics platforms has changed over time, comparing precision, sensitivity and specificity as throughput increases.

Learn more

WebinarFrom discovery to clinical insights – the power of integrating proteomics and genomics data

The value of adding high-plex proteomics to existing genomics data and how proteogenomic approaches accelerate drug target discovery and repurposing. Watch this presentation given by Maik Pietzner, PhD, at ESHG 2024.

Learn more

Explore webinars in our interactive viewer